News

How can we improve infection control in such a tricky environment?

In case you missed them, we’ve compiled a list of the latest recalls posted this week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Contagion® will be covering the conference, and so, keep a look out for session coverage as well as interviews with some of the key presenters.

The Centers for Disease Control and Prevention (CDC) announced an investigation into a multistate outbreak of E. coli O157:H7 infections, now impacting 7 states.

Invasive meningococcal disease doesn’t always present with the classic symptoms of stiff neck and headache—for a small subset of IMD patients, the abdomen is where the disease shows itself.

New strains of the mumps virus are not to blame for the recent resurgence of cases, say researchers in a new study, instead pinning the recent outbreaks on declining protective effects of the mumps vaccine over time.

Organ donor recipients taking anti-rejection medications are at risk for infection, but a new study has found that the rate of death from such infections has declined significantly.

The contaminated chicken salad has sickened over 260 individuals in 8 states and claimed 1 life.

In an era of in which everything is political—and politics is perhaps more polarized than ever before—Dr. Adams is advocating for what APHA Executive Director Georges Benjamin, MD, described as the “sensible middle.”

A rare cholera outbreak on Vancouver Island, Canada has been linked with the consumption of herring eggs.

One dose of microbiota-based therapy proved more effective than 2 at wiping out recurrent C. difficile infection.

On National Youth HIV/AIDS Awareness Day we take a closer look at how the HIV/AIDS epidemic impacts younger individuals and what can be done to cut back on new diagnoses.

Representatives from Novavax, Inc., an American-based biotechnology company, presented data at the recent World Vaccine Congress in Washington, DC, on their vaccines under development for the flu and RSV.

Local Panera Bread locations are being explored as a potential source of infection.

The name change represents a new chapter for the organization after 50 years of service, in addressing the scope of health care challenges in the region today.

Although resistant strains have been reported sporadically, in recent years, there have been no reports of what an international team of researchers has described as “sustained transmission”—until now.

In case you missed them, we’ve compiled a list of the latest recalls posted this week.

The multistate outbreak of Salmonella infections that have been linked to kratom continues to grow.

Study finds antibiotic use alters native gut bacteria that normally compete with C. diff for nutrients.

In case you missed them, we've compiled the top five infectious disease articles from this past week.

In a new international study, a team of European authors says that antibiotic use for preventative purposes is too high in pediatric hospitals, prompting a call for better antibiotic stewardship efforts.

Results from a Johns Hopkins study conducted at Frere Hospital in South Africa indicate that emergency departments play a critical role in promoting HIV testing.

Paratek’s omadacycline moves another step toward approval.

The risk comes after it was found that surgical instruments used for orthopedic and spine surgeries were not cleaned properly and consequently, the sterilization of those instruments was compromised.

Novel HIV drug doravirine shows good potential in a recent clinical trial comparing it with established therapy darunavir.

Investigators set out to find out why pertussis rates in the United States have been rising steadily despite the availability of a vaccine.

The first case of gonorrhea resistant to available first-line antibiotics has been reported in the United Kingdom.

The US Centers for Disease Control and Prevention (CDC) has requested funds for a new high containment lab; let's give it to them.

Health officials around the United States are still recommending the flu shot for late-season protection against the second wave of flu caused by influenza B.